Corylus americana pollen

Overview

Description
An extract from Corylus americana pollen used in allergy testing.
Description
An extract from Corylus americana pollen used in allergy testing.
DrugBank ID
DB10363
Type
Biotech
US Approved
YES
Other Approved
NO
Clinical Trials
Phase 0
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Therapeutic Categories
  • Non-Standardized Pollen Allergenic Extract

Identification

Summary

Corylus americana pollen is an extract from Corylus americana pollen used in allergy testing.

Generic Name
Corylus americana pollen
DrugBank Accession Number
DB10363
Background

Corylus americana pollen is the pollen of the Corylus americana plant. Corylus americana pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • hazelnut pollen extract

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
American Hazelnut PollenSolution0.001 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
American Hazelnut PollenSolution0.1 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
American Hazelnut PollenSolution0.05 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
American Hazelnut PollenSolution0.05 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag
American Hazelnut PollenSolution40000 [PNU]/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
ZGS382Y3AV
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910540
RxNav
852281

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous40000 [PNU]/1mL
Injection, suspensionSubcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal1000 [PNU]/1mL
Injection, solutionPercutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.05 g/1mL
Injection, solutionSubcutaneous0.10 g/1mL
Injection, solutionSubcutaneous20000 [PNU]/1mL
Injection, solutionSubcutaneous40000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
InjectionCutaneous; Intradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53